{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:49:35Z","timestamp":1783640975170,"version":"3.55.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Precis:<\/jats:title>\n            <jats:p>In primary open-angle glaucoma (POAG), micropulse trans-scleral cyclophototherapy (MPTCP) is effective in lowering intraocular pressure (IOP), but its effects are not permanent. Hence, it can serve as a temporizing measure before definitive glaucoma surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>There is limited data on MPTCP in POAG. This is the first study that looks at MPTCP treatment specifically in POAG patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>This is an interventional, single-institution exploratory case series with 55 eyes of 48 patients with POAG. Data was collected from clinical records, including patient demographics, clinical information, number of glaucoma medications, MPTCP laser settings, complications, and clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Patients had a mean age of 67.3\u00b114.1 years with a preponderance of males. IOP was 24.8\u00b11.0\u2009mm\u2009Hg before MPTCP and decreased to 19.7\u00b11.1, 21.9\u00b11.1, and 21.8\u00b11.1\u2009mm\u2009Hg at postoperative month 3, 6, and 12 respectively. IOP remained below pretreatment levels throughout the postoperative period (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). Visual acuity and mean deviation remained stable before and after MPTCP. No eyes had complications. Number of glaucoma medications remained the same after MPTCP. Four eyes required additional oral acetazolamide at postoperative month 1 for IOP control. Seventeen eyes subsequently required further surgical intervention after 9.84 months. Maximal IOP decrease was greater when there were higher power settings, higher preoperative IOP, and better preoperative visual acuity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions and Relevance:<\/jats:title>\n            <jats:p>The IOP lowering effect of MPTCP treatment in patients with POAG was found to be modest and transient with a similar medication burden, and definitive glaucoma surgery was needed in a number of patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ijg.0000000000001925","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:04:32Z","timestamp":1628474672000},"page":"911-920","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["One-Year Outcomes of Micropulse Cyclophototherapy for Primary Open-angle Glaucoma"],"prefix":"10.1097","volume":"30","author":[{"given":"Weihan","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Yu Ting","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Chew","family":"Wong","sequence":"additional","affiliation":[{"name":"Research Support Unit, National University Health System, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cecilia","family":"Aquino","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"R1-20250803","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"R2-20250803","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/jcm9030761","article-title":"Primary open angle glaucoma and vascular risk factors: a review of population based studies from 1990 to 2019","volume":"9","author":"Grzybowski","year":"2020","journal-title":"J Clin Med"},{"key":"R3-20250803","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/IJG.0000000000001057","article-title":"Safety and efficacy of diode laser transscleral cyclophotocoagulation in eyes with good visual acuity","volume":"27","author":"Shah","year":"2018","journal-title":"J Glaucoma"},{"key":"R4-20250803","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma","volume":"38","author":"Tan","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R5-20250803","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1177\/1120672120914231","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma","volume":"31","author":"Tekeli","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R6-20250803","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2147\/OPTH.S226554","article-title":"Outcome of MicroPulse(\u00ae) transscleral photocoagulation in different types of glaucoma","volume":"13","author":"Al Habash","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R7-20250803","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ceo.12360","article-title":"Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study","volume":"43","author":"Aquino","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"R8-20250803","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/1120672119839303","article-title":"Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma","volume":"30","author":"Nguyen","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"R10-20250803","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00417-020-04611-0","article-title":"Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma","volume":"258","author":"Vig","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250803","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10103-019-02934-x","article-title":"Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up","volume":"35","author":"Preda","year":"2020","journal-title":"Lasers Med Sci"},{"key":"R12-20250803","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1120672119877586","article-title":"Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction","volume":"31","author":"Souissi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R13-20250803","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IJG.0000000000001339","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision","volume":"28","author":"Varikuti","year":"2019","journal-title":"J Glaucoma"},{"key":"R14-20250803","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5935\/0004-2749.20190076","article-title":"Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results","volume":"82","author":"Jammal","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"R15-20250803","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients","volume":"28","author":"Zaarour","year":"2019","journal-title":"J Glaucoma"},{"key":"R16-20250803","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/IJG.0000000000001023","article-title":"Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results","volume":"27","author":"Yelenskiy","year":"2018","journal-title":"J Glaucoma"},{"key":"R17-20250803","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","article-title":"Micropulse cyclophotocoagulation: initial results in refractory glaucoma","volume":"26","author":"Emanuel","year":"2017","journal-title":"J Glaucoma"},{"key":"R18-20250803","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/IJG.0000000000000934","article-title":"Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma","volume":"27","author":"Williams","year":"2018","journal-title":"J Glaucoma"},{"key":"R19-20250803","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10103-015-1856-9","article-title":"Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma","volume":"31","author":"Kuchar","year":"2016","journal-title":"Lasers Med Sci"},{"key":"R20-20250803","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J Curr Glaucoma Pract"},{"key":"R21-20250803","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.9.5.22","article-title":"Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a randomized comparative study","volume":"9","author":"Moussa","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R22-20250803","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jcjo.2020.03.010","article-title":"Histopathologic changes in cadaver eyes after MicroPulse and continuous wave transscleral cyclophotocoagulation","volume":"55","author":"Maslin","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"R23-20250803","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/IJG.0000000000001443","article-title":"MP3 Plus: A Modified Micropulse Transscleral Cyclophototherapy Technique for the Treatment of Refractory Glaucoma","volume":"29","author":"Wong","year":"2020","journal-title":"J Glaucoma"},{"key":"R24-20250803","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archopht.1992.01080190071032","article-title":"Complications of glaucoma surgery. Ocular decompression retinopathy","volume":"110","author":"Fechtner","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R25-20250803","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3928\/1542-8877-19960201-12","article-title":"Retinal hemorrhages associated with ocular decompression after glaucoma surgery","volume":"27","author":"Dudley","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"R26-20250803","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/15428877-20060701-15","article-title":"Optical coherence tomography findings in ocular decompression retinopathy","volume":"37","author":"Bui","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0000000000001925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T20:05:32Z","timestamp":1754251532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0000000000001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0000000000001925","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"2021-01-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}